Sitemap > Breaking Research > Cancer Immunotherapy
Displaying 1051 - 1100 of 1864 results
- Expression of an Ovarian Cancer Anti-Idiotype Antibody (6B11VLVHCH3) in Chinese Hamster Ovary (CHO) Cells with Improved Immunoactivity and Stability Over Proteins Expressed in Prokaryotic Cells.
- Antitumor Effect of an Antibody Against Gastrointestinal Cancer-Associated Antigen CA19.9.
- Antiangiogenic agents: an update on small molecule VEGFR inhibitors.
- Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits macrophage inflammatory protein 1alpha expression and secretion in mouse myeloma cells.
- Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels.
- Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine.
- New cancer therapy using genetically-engineered oncolytic Sendai virus vector.
- Targeting IFN-{alpha} to B Cell Lymphoma by a Tumor-Specific Antibody Elicits Potent Antitumor Activities.
- PDGFRbeta and HIF-1alpha Inhibition with Imatinib and Radioimmunotherapy of Experimental Prostate Cancer.
- Functional Expression of TLR9 is Associated to the Metastatic Potential of Human Lung Cancer Cell: Functional Active Role of TLR9 on Tumor Metastasis.
- Agonists of Toll-like Receptor 9 Containing Synthetic Dinucleotide Motifs.
- Novel plant virus-based vaccine induces protective CTL-mediated antiviral immunity through dendritic cell maturation.
- Gene transfer of CD40-ligand to dendritic cells stimulates interferon-gamma production to induce growth arrest and apoptosis of tumor cells.
- Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
- Characterization and application of three novel monoclonal antibodies against human 4-1BB: distinct epitopes of human 4-1BB on lung tumor cells and immune cells.
- Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial.
- Anticancer activity of oncolytic adenovirus vector armed with IFN-alpha and ADP is enhanced by pharmacologically controlled expression of TRAIL.
- Modified vaccinia virus Ankara as a vector for suicide gene therapy.
- Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo.
- Antitumor activity of cytokine-induced killer cells against human lung cancer.
- Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.
- A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours.
- Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies.
- Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines.
- Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia. A phase I-II study.
- Cetuximab for the treatment of colorectal cancer.
- Immunity against Tumor Angiogenesis Induced by a Fusion Vaccine with Murine {beta}-Defensin 2 and mFlk-1.
- Treatment of invasive retinoblastoma in a murine model using an oncolytic picornavirus.
- Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus.
- Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways.
- Antimetastatic activity of a preventive cancer vaccine.
- A Phase II Prospective Multi-institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903.
- Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells.
- Bevacizumab and albumin-bound Paclitaxel treatment in metastatic breast cancer.
- Interleukin-2 inhalation Therapy Temporarily Induces Asthma-like Airway Inflammation.
- Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.
- Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
- Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic Peptide mimotopes: implication for Peptide-based active immunotherapy.
- Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells.
- High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial.
- Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma.
- The Role of the CTLA4 Blockade in the Treatment of Malignant Melanoma.
- Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen.
- A novel mimovirus vaccine containing survivin epitope with adjuvant IL-15 induces long-lasting cellular immunity and high antitumor efficiency.
- Experimental therapeutic approaches to adenocarcinoma: The potential of tumor cells engineered to express MHC class II molecules combined with naked DNA interleukin-12 gene transfer.
- Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer.
- Novel long-lasting interferon alpha derivatives designed by glycoengineering.
- Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab.
- Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan.
- Effect of Tumor Microenvironment Modulation on the Efficacy of Oncolytic Virus Therapy.